User profiles for Beth E. Snitz

Beth E. Snitz

Associate Professor of Neurology, University of Pittsburgh
Verified email at upmc.edu
Cited by 14913

Clinical versus mechanical prediction: a meta-analysis.

WM Grove, DH Zald, BS Lebow, BE Snitz… - Psychological …, 2000 - psycnet.apa.org
The process of making judgments and decisions requires a method for combining data. To
compare the accuracy of clinical and mechanical (formal, statistical) data-combination …

Frequent amyloid deposition without significant cognitive impairment among the elderly

…, SK Ziolko, JA James, BE Snitz… - Archives of …, 2008 - jamanetwork.com
Objective To characterize the prevalence of amyloid deposition in a clinically unimpaired
elderly population, as assessed by Pittsburgh Compound B (PiB) positron emission …

Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes

BE Snitz, AW MacDonald III, CS Carter - 2006 - academic.oup.com
Cognitive deficits may index genetic liability for schizophrenia and are candidate endophenotypes
for the illness. In order to compare the degree of sensitivity among cognitive tasks to …

Ginkgo biloba for prevention of dementia: a randomized controlled trial

…, JA Robbins, RP Tracy, NF Woolard, L Dunn, BE Snitz… - Jama, 2008 - jamanetwork.com
Context Ginkgo biloba is widely used for its potential effects on memory and cognition. To
date, adequately powered clinical trials testing the effect of G biloba on dementia incidence …

[HTML][HTML] Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease

…, K Blennow, HJ Aizenstein, WE Klunk, BE Snitz… - Nature medicine, 2023 - nature.com
An unresolved question for the understanding of Alzheimer’s disease (AD) pathophysiology
is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) …

Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial

BE Snitz, ES O'Meara, MC Carlson, AM Arnold… - Jama, 2009 - jamanetwork.com
Context The herbal product Ginkgo biloba is taken frequently with the intention of improving
cognitive health in aging. However, evidence from adequately powered clinical trials is …

Implementation of subjective cognitive decline criteria in research studies

…, AJ Saykin, S Sikkes, CM Smart, BE Snitz… - Alzheimer's & …, 2017 - Elsevier
Introduction Subjective cognitive decline (SCD) manifesting before clinical impairment
could serve as a target population for early intervention trials in Alzheimer's disease (AD). A …

Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies

…, AJ Saykin, MJ Slavin, BE Snitz… - Journal of …, 2015 - content.iospress.com
Research increasingly suggests that subjective cognitive decline (SCD) in older adults, in
the absence of objective cognitive dysfunction or depression, may be a harbinger of non-…

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

…, MD Ikonomovic, JA Saxton, BE Snitz… - Journal of …, 2007 - Soc Neuroscience
The amyloid cascade hypothesis suggests that the aggregation and deposition of amyloid-β
protein is an initiating event in Alzheimer's disease (AD). Using amyloid imaging technology…

Amyloid imaging in mild cognitive impairment subtypes

DA Wolk, JC Price, JA Saxton, BE Snitz… - Annals of Neurology …, 2009 - Wiley Online Library
Objective We utilized the amyloid imaging ligand Pittsburgh Compound B (PiB) to determine
the presence of Alzheimer's disease (AD) pathology in different mild cognitive impairment (…